BioLux: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BioLux
Largest movements
- Cash -€12,884
down €12,884 (-78.9%), from €16,320 to €3,436
mainly Net result for the year (-€12,409) and Tax, wage and social debts (-€2,991)
- Receivables within one year -€1,018
down €1,018 (-10.2%), from €9,972 to €8,954
of which Other amounts receivable: -€3,074
- Reserves -€11,549
no longer reported in 2025 (was €11,549)
- Tax, wage and social debts -€2,991
down €2,991 (-58.5%), from €5,113 to €2,122
- Trade debts +€2,130
up €2,130 (+41.9%), from €5,088 to €7,219
- Profit (loss) carried forward -€860
new in 2025: -€860
- Other debts -€632
no longer reported in 2025 (was €632)
- Gross operating margin -€18,016
down €18,016, from €6,580 to -€11,436
- Taxes -€1,766
down €1,766 (-90.8%), from €1,944 to €178
- Other operating charges +€295
up €295 (+62.6%), from €472 to €767
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €26,383 | €12,481 | -€13,902 | -52.7% |
| Fixed assets | 21/28 | €91 | €91 | = | 0.0% |
| Financial fixed assets | 28 | €91 | €91 | = | 0.0% |
| Current assets | 29/58 | €26,292 | €12,390 | -€13,902 | -52.9% |
| Amounts receivable within one year | 40/41 | €9,972 | €8,954 | -€1,018 | -10.2% |
| Trade receivables | 40 | €5,590 | €7,647 | +€2,057 | +36.8% |
| Other amounts receivable | 41 | €4,382 | €1,307 | -€3,074 | -70.2% |
| Cash at bank and in hand | 54/58 | €16,320 | €3,436 | -€12,884 | -78.9% |
| Total equity and liabilities | 10/49 | €26,383 | €12,481 | -€13,902 | -52.7% |
| Equity | 10/15 | €15,549 | €3,140 | -€12,409 | -79.8% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Reserves | 13 | €11,549 | - | -€11,549 | |
| Distributable reserves | 133 | €11,549 | - | -€11,549 | |
| Profit (loss) carried forward | 14 | - | -€860 | -€860 | |
| Amounts payable | 17/49 | €10,834 | €9,341 | -€1,493 | -13.8% |
| Amounts payable within one year | 42/48 | €10,834 | €9,341 | -€1,493 | -13.8% |
| Trade debts | 44 | €5,088 | €7,219 | +€2,130 | +41.9% |
| Suppliers | 440/4 | €5,088 | €7,219 | +€2,130 | +41.9% |
| Taxes, remuneration and social security | 45 | €5,113 | €2,122 | -€2,991 | -58.5% |
| Taxes | 450/3 | €5,113 | €2,122 | -€2,991 | -58.5% |
| Other amounts payable | 47/48 | €632 | - | -€632 | |
| Other operating charges | 640/8 | €472 | €767 | +€295 | +62.6% |
| Gross operating margin | 9900 | €6,580 | -€11,436 | -€18,016 | |
| Operating profit (loss) | 9901 | €6,108 | -€12,203 | -€18,312 | |
| Financial income | 75/76B | €50 | €32 | -€18 | -36.7% |
| Recurring financial income | 75 | €50 | €32 | -€18 | -36.7% |
| Financial charges | 65/66B | €68 | €59 | -€9 | -13.5% |
| Recurring financial charges | 65 | €68 | €59 | -€9 | -13.5% |
| Profit (loss) for the period before taxes | 9903 | €6,090 | -€12,231 | -€18,321 | |
| Income taxes | 67/77 | €1,944 | €178 | -€1,766 | -90.8% |
| Profit (loss) for the period | 9904 | €4,146 | -€12,409 | -€16,555 | |
| Profit (loss) for the period to be appropriated | 9905 | €4,146 | -€12,409 | -€16,555 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.